Susan Gubar (New York Times)
Primer: How To Speak Basic Biotech, From 'Transformative' To 'Valley Of Death'
Carey Goldberg (WBUR)
The difficult search for the right recipe in cancer immunotherapy
Lisa Jarvis (C&EN)
Critical Condition: Inside Pfizer’s Drug Supply Problem
Erika Fry (Fortune)
Demystifying Statistics in Medicine: An Approach to Appraising Randomized Controlled Trials
Zahra Sohani (Medshr)
IDO Don’ts: After Immunotherapy Failure, Experts Say Slow Down
Ben Fidler (Xconomy)
The Outcome of My Clinical Trial Is a Mystery
Emma Yasinski (The Atlantic)